jRCT2031230469进行中（未招募）不适用
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 400
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 40age old over 至 85age old under（—）
- 性别
- All
入选标准
- •Male or female aged 40 to 85 years at the time of informed consent.
- •Patient meets American College of Rheumatology Criteria (ACR) for Osteoarthritis of the knee
- •Patient who fully understands the contents of the study and is competent to give consent.
排除标准
- •Patient has renal, hepatic, cardiac, pancreatic, or metabolic diseases or hematologic abnormality.
- •Patient is on a current treatment for malignancy or has a history of malignancy within the past 5 years.
- •Patient who are pregnant or may be pregnant, who wants to be pregnant during the trial period, patients who are nursing. Patient who cannot agree on proper contraception in the patient or the patient's female partner is a pregnant woman.
结局指标
主要结局
-
Mean change from baseline on the numerical rating scale (NRS) for pain
次要结局
未报告次要终点
研究者
相似试验
已完成
2 期
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.JPRN-jRCT2080224985Asahi Kasei Pharma Corporation400
尚未招募
2 期
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.Pain due to osteoarthritisJPRN-jRCT2031230469Kudo Katsuyasu400
已完成
2 期
Randomized, Double-Blind Study of AK1830 in Patients with low back paiow back painJPRN-jRCT2080225352Asahi Kasei Pharma Corporation400
已完成
2 期
Follow ups of patients in AK1830 Phase II Studiesosteoarthritis, chronic lumbar painJPRN-jRCT2031210566Kudo Katsuyasu10
已完成
1 期
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200119Shimizu Tomohito20